(Q34512590)

English

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

scientific article

Statements

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group (English)
P Ghadirian
P de los Rios
Hereditary Breast Cancer Clinical Study Group
1 December 2000
1876-1881

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit